e-ISSN: Pending
Failure-mode index

Search what already failed

A searchable index of real negative results, null findings, and replication failures from the published literature — so you can learn what didn't work before repeating it.

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record (title, authors, DOI) compiled from open scholarly databases, with the abstract shown in full only where the paper is openly licensed (e.g. Creative Commons); otherwise a short excerpt is shown for reference under fair use. WASTE classifies each work by failure type; classifications are automated and approximate.

19879 results in Negative / Null Result Report · page 484 of 663

Negative / Null Result ReportOpen accessMedicine

Bayesian Re-analysis of Two-Year Outcomes in the Platelet-Rich Plasma in Achilles Tendon Healing 2 (PATH-2) Trial: Platelet-Rich Plasma for Achilles Tendon Rupture.

Le J, Patel M, Atschinow A et al. · 2026 · Cureus

The platelet-rich plasma in achilles tendon healing 2 (PATH-2) trial is the largest randomized study of platelet-rich plasma (PRP) in acute Achilles tendon rupture. While the original frequentist analysis showed no significant benefit,…

View details →DOI: 10.7759/cureus.102519
Negative / Null Result ReportOpen access

Depressive Behaviors and Gambling

Robert Ladouceur, Marie Mayrand · 1987

The perceptions of control regarding an objectively uncontrollable task (American Roulette) by depressive and nondepressive subjects were compared. Monetary risk behavior and subjective control did not differ significantly between the two…

View details →DOI: 10.2466/pr0.1987.60.3.1019
Negative / Null Result ReportOpen accessMedicine

Analysis of changes in glomerular lesions in children diagnosed with IgA nephropathy following immunosuppressive therapy.

Wang J, Liu LL, Huang L et al. · 2026 · BMC nephrology

Background The European STOP study showed that glucocorticoids (with/without immunosuppressants) did not delay disease progression in adults with IgA nephropathy (IgAN). However, pediatric IgAN is characterized by more severe acute…

View details →DOI: 10.1186/s12882-026-05101-x
Negative / Null Result ReportOpen accessMedicine

Preclinical Safety Evaluation of <i>Leuconostoc lactis</i> DMLL10 Isolated from Kimchi in Rats.

Park HJ, Park S, Heo S et al. · 2026 · Journal of microbiology and biotechnology

Leuconostoc lactis DMLL10 is a novel strain isolated from kimchi. The strain did not exhibit toxicity in genetic tests. This study aims to conduct a preclinical safety assessment by performing repeated-dose toxicity studies in animals. In…

View details →DOI: 10.4014/jmb.2601.01021
Negative / Null Result ReportOpen accessMedicine

Hemi-ECMO: A Novel Method of Left Ventricular Afterload Reduction for Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO).

Said C, Hayward C, Stevens M et al. · 2026 · Bioengineering (Basel, Switzerland)

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has failed to demonstrate mortality benefit in randomised controlled trials of cardiogenic shock. We aimed to determine whether a novel 'Hemi-ECMO' configuration, involving aortic…

View details →DOI: 10.3390/bioengineering13050499
Negative / Null Result ReportMedicine

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).

Endo S, Tanaka R, Yamaguchi T et al. · 2026 · Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Background Large type 3 (≥ 8 cm) and type 4 gastric cancers are associated with extremely poor prognoses. The phase III JCOG0501 trial, which evaluated neoadjuvant S-1 plus cisplatin, failed to demonstrate any survival benefits. Docetaxel,…

View details →DOI: 10.1007/s10120-025-01705-8
Negative / Null Result Report

Paclitaxel Drug Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A U.S. Single-Center Experience with the AGENT balloon

Chaudhari A, Rosenstein ZM, Kamal R et al. · 2025 · Preprint

Background Intracranial atherosclerotic disease (ICAD) is associated with up to 10% of ischemic strokes and a high risk of recurrence. Endovascular treatments including percutaneous transluminal angioplasty and stenting have failed to…

View details →DOI: 10.1101/2025.09.17.25336036
Negative / Null Result ReportMedicine

ECLS-SHOCK Trial.

Thery G, Noly PE, Cavayas YA et al. · 2025 · Seminars in thoracic and cardiovascular surgery

ECLS-SHOCK is the largest randomized control trial on Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) in Acute Myocardial Infarction-related Cardiogenic Shock (AMI-CS). Unfortunately, ECLS-SHOCK failed to demonstrate a…

View details →DOI: 10.1053/j.semtcvs.2025.01.004
Negative / Null Result ReportOpen accessMedicine

Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trial.

Liu S, Chen B, Zhu Y et al. · 2025 · The oncologist

Background Previous results of our trial demonstrated that the addition of induction chemotherapy (IC) prior to definitive chemoradiotherapy (CRT) failed to significantly improve the response rate or 3-year survival in patients with…

View details →DOI: 10.1093/oncolo/oyae295
Negative / Null Result ReportMedicine

Minimizing placebo responses in clinical trials.

Emborg C, Kothari SF, Finnerup NB et al. · 2025 · Handbook of clinical neurology

Over the past decades, a growing number of clinical trials in neurologic conditions have failed to demonstrate superiority of active treatments over placebo. A key question in this context is whether an increase in placebo response can…

View details →DOI: 10.1016/b978-0-443-29884-4.00018-2
Negative / Null Result ReportOpen accessMedicine

Revisiting elevated HDL cholesterol, cerebral hemodynamic improvement in asymptomatic carotid artery disease: A longitudinal <sup>15</sup>O-Gas PET study.

Hattori Y, Abe S, Kakino Y et al. · 2026 · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Interventional trials with high-density lipoprotein cholesterol (HDL-C)-raising drugs have generally failed to demonstrate a beneficial effect on cardiovascular outcomes, although low HDL-C levels confer the risk of cerebrocardiovascular…

View details →DOI: 10.1016/j.neurot.2026.e00849
Negative / Null Result ReportOpen accessMedicine

Endovascular Treatment for Medium and Distal Vessel Occlusion Stroke: Are We Missing the Point?

Murillo-Olaizola A, Rodrigo-Gisbert M, Requena M et al. · 2026 · Stroke (Hoboken, N.J.)

Background Recent randomized controlled trials of endovascular treatment (EVT) for distal and medium vessel occlusion (DMVO) stroke did not demonstrate clinical benefit over best medical therapy and suggested potential safety concerns. We…

View details →DOI: 10.1161/svin.125.002137
Negative / Null Result ReportOpen accessChemistry

PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation

Tóth Štefan, Olexa Peter, Hertelyová Zdenka et al. · 2020 · Open Chemistry

The aim of this study was to detect the concentrations of PCSK9 in various subclinical stages of atherosclerosis and to highlight its relationship with inflammation. One hundred and fifty-nine healthy patients were divided into three groups, based on the extent of atherosclerotic changes in the carotid artery: a group without identifiable atherosclerosis, cIMT>75‰ and an asymptomatic plaque group. The PCSK9 was measured by ELISA and hsCRP by the immunoturbidimetric method. Vascular changes were identified by a carotid ultrasound. PCSK9 was elevated, when comparing the healthy group with the cI

View details →DOI: 10.1515/chem-2020-0147
Negative / Null Result ReportOpen accessMedicine

Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials.

Brenner H, Sergeev D, Heisser T et al. · 2025 · Alimentary pharmacology & therapeutics

NordICC, the first randomised trial on long-term effects of screening colonoscopy, failed to demonstrate a significant reduction in colorectal cancer (CRC) mortality. We compared reported 10-year CRC mortality results from NordICC with…

View details →DOI: 10.1111/apt.70231
Negative / Null Result ReportMedicine

Compensating for the mobile menace with extra effort: A pupillometry investigation of the mere presence effect of smartphones.

Steendam ST, Prutean N, Clybouw F et al. · 2024 · Biological psychology

Previous research suggests that the mere presence of a smartphone can detrimentally affect performance. However, other studies failed to observe such detrimental effects. A limitation of existing studies is that no indexes of (potentially…

View details →DOI: 10.1016/j.biopsycho.2024.108893
Negative / Null Result ReportMedicine

Enriching Clinical Trials Enrolling Children With Cerebral Malaria Using Admission Demographics, Physical Examination and Point-of-care Testing Results.

Imam R, Chastang KM, Olowojesiku R et al. · 2025 · The Pediatric infectious disease journal

Background Multiple clinical trials evaluating therapies for cerebral malaria (CM) have failed to demonstrate improved outcomes. This may derive from inclusion of children at all risk levels, including those at low risk of mortality or…

View details →DOI: 10.1097/inf.0000000000004581
Negative / Null Result ReportMedicine

Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale.

Wolpe N, Perrottelli A, Giuliani L et al. · 2025 · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

The negative symptoms of schizophrenia can determine functional outcome in patients. Despite its clinical significance, no treatment exists to date, as numerous pharmacological and non-pharmacological clinical trials have failed to…

View details →DOI: 10.1016/j.euroneuro.2024.12.016
Negative / Null Result ReportOpen accessMedicine

Does Combined Stimulant and Psychosocial Treatment in Childhood Attention-Deficit/Hyperactivity Disorder Protect Against Future Substance Use?

Bommersbach TJ, Saliba M, Gilman CK et al. · 2025 · JAACAP open

Objective Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for future substance use. Stimulant medication has largely failed to demonstrate protection against future substance use, but no studies have assessed whether…

View details →DOI: 10.1016/j.jaacop.2025.05.004
Negative / Null Result Report

A high fraction of inspired oxygen does not mitigate atelectasis-induced lung tissue hypoxia or injury in experimental acute respiratory distress syndrome

Tojo K, Yazawa T · 2024 · Preprint

Abstract Background Although alveolar hyperoxia exacerbates lung injury, clinical studies have failed to demonstrate the beneficial effects of lowering the fraction of inspired oxygen (F I O 2 ) in patients with acute respiratory distress…

View details →DOI: 10.21203/rs.3.rs-4449408/v1
Negative / Null Result ReportMedicine

Natural Course of Untreated Obstructive Sleep Apnea in Adults with Coronary Artery Disease in the RICCADSA Cohort.

Peker Y, Saygin M, Celik Y et al. · 2026 · Annals of the American Thoracic Society

Rationale Recent randomized controlled trials failed to show cardiovascular benefits of treating obstructive sleep apnea (OSA) in intention-to-treat analyses which has been a matter of debate since publication of the results. Objectives To…

View details →DOI: 10.1093/annalsats/aaoag072
Negative / Null Result ReportMedicine

Perfusion-bypass recipient mismatch as a potential risk factor for perioperative ischemic stroke following single-barrel STA-MCA bypass for symptomatic atherosclerotic carotid occlusive disease.

Gaub M, Shaffer KV, Patel P et al. · 2026 · Clinical neurology and neurosurgery

Objective EC-IC bypass for symptomatic atherosclerotic internal carotid and middle cerebral artery chronic occlusion (AIMCAO) failed to show benefit over medical management in previous randomized controlled trials. We explored how a…

View details →DOI: 10.1016/j.clineuro.2026.109417
Negative / Null Result ReportMedicine

The Cardiovascular Effects of Acute and Chronic Hypoglycemia.

Dintakurti A, Parikh MA, Silver RJ et al. · 2025 · Cardiology in review

Large-scale clinical trials of intensive glycemic control have failed to show cardiovascular benefit, with hypoglycemia implicated as a key factor. Increasing evidence suggests hypoglycemia is not merely a complication of diabetes therapy…

View details →DOI: 10.1097/crd.0000000000001114
Negative / Null Result ReportMedicine

Role of sequential functional echocardiography in predicting clinically apparent patent ductus arteriosus in preterm very low birth weight newborns: An observational study.

Bhardwaj A, Saili A, Yadav DK et al. · 2025 · Journal of neonatal-perinatal medicine

BackgroundThe prolonged ductal patency in preterm newborns despite being associated with short- and long-term morbidities has failed to show significant improvement in the long-term outcome with routine ductal treatment. Echocardiography…

View details →DOI: 10.1177/19345798251343494